The ability of FGF19 to induce hepatocyte proliferation observed in the BrdU incorporation studies has been suggested as the cause for the eventual development of hepatocellular carcinomas in FGF19 transgenic mice [24]. Here, FGF19 is linked to hepatocellular carcinoma.